Zhi Biology (300122) March 8 Evening announced the annual report, 2010 the company to achieve total operating income of 737 million yuan, increased by 22.06% per cent, attributable to the shareholders of the listed company net profit of 256 million yuan, the year-on-year increase of 10.88%, the basic earnings of 0.69 yuan, increased 7.81%. The company intends to December 31, 2010 The total share capital 400 million shares as the base, to all shareholders 10 shares of cash dividend 2.00 yuan (including tax). The company also announced that the company intends to use over 361 million yuan to raise funds to invest in Group A, C group of epidemic cerebrospinal meningitis, Hib combined vaccine industrialization Project. The project by the wholly-owned subsidiary of Beijing Green Bamboo for the implementation of the main body, the company will be based on the actual progress of the project, through the Beijing Green Bamboo to raise capital investment in the way. After the capital increase, Beijing Green bamboo is still a wholly-owned subsidiary of the company. Responsible Editor: NF054
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
